Biomedical Systems, a global provider of centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services.
Biomedical Systems Announces Vice President, Imaging Services
August 27, 2008 – St. Louis, MO – Biomedical Systems, a global leader in centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services. Dranoff will continue with his current responsibilities while growing a team of global business development directors for Biomedical Systems, Imaging Services. The business unit has experienced significant growth since Dranoff joined the division in 2005, and most recently served as Managing Director, Commercial Operations.
"We have grown the imaging business to a point where we see a need for expanding the Business Development team. Sam has the proven experience and talent to grow and manage this team as well as the vision to see it succeed. That is why I'm so excited that he has accepted this new position and I'm confident that he will add great value in his new role." said Jesse Bowden, President of Imaging Services, Biomedical Systems.
Biomedical Systems is a fully digital imaging core lab that supports clinical trials in dozens of therapeutic categories. Leveraging combined corporate resources that includes ECG core lab and respiratory core lab, Biomedical Imaging Services provides sponsors unmatched diagnostic service offerings on a global basis.
Biomedical Systems is a global provider of centralized diagnostic services for the pharmaceutical and medical device industries. With offices in North America, Europe and Asia, Biomedical Systems has worked with over 11,000 investigative sites in 75 countries around the world for Phase I - IV clinical trials. Biomedical Systems centralized services include the acquisition, analysis and management of data for Cardiac, Imaging and Respiratory modalities used to determine safety and efficacy for drugs and devices in clinical trials. For more information about Biomedical Systems, please contact Traci Cardenas, Marketing Manager at 1-800-877-6334 (3338) or via email, tcardenas@biomedsys.com. Additional information can be found on the company website at www.biomedsys.com.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.